UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial

Brain, behavior, & immunity. Health, 2023-02, Vol.27, p.100585-100585, Article 100585

2023

Volltextzugriff (PDF)

Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review

Current medicinal chemistry, 2015-01, Vol.22 (16), p.1892-1902

2015

Volltextzugriff (PDF)

SP0013 Is It Enough Just To Treat Inflammation To Reduce Cardiovascular Risk?

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.5-5

Nurmohamed, M.T.

2016

Volltextzugriff (PDF)

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

Rheumatology international, 2017-04, Vol.37 (4), p.487-493

2017

Volltextzugriff (PDF)

Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women

Seminars in arthritis and rheumatism, 2023-10, Vol.62, p.152233-152233, Article 152233

2023

Volltextzugriff (PDF)

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152132-152132, Article 152132

2023

Volltextzugriff (PDF)

Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence

PloS one, 2019-08, Vol.14 (8), p.e0221290

2019

Volltextzugriff (PDF)

SP0117 Rheumatic diseases and cardiovascular risk: Implications for clinical practice

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.29-29

Nurmohamed, M.T.

2013

Volltextzugriff (PDF)

FRI0148 Determination of The Lipid Profile in Active Disease Leads To Incorrect Cardiovascular Risk Prediction in Early RA Patients: Table 1

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.482-482

2016

Volltextzugriff (PDF)

Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease – the eye for a heart study

Seminars in arthritis and rheumatism, 2020-12, Vol.50 (6), p.1535-1541

2020

Volltextzugriff (PDF)

THU0116 Lipid profile and cardiovascular risk in subjects at risk for developing rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.280

2018

Volltextzugriff (PDF)

Association of Somatic Comorbidities and Comorbid Depression With Mortality in Patients With Rheumatoid Arthritis: A 14‐Year Prospective Cohort Study

Arthritis care & research (2010), 2016-08, Vol.68 (8), p.1055-1060

2016

Volltextzugriff (PDF)

SAT0131 Uric Acid is Associated with Metabolic Syndrome in Longstanding Rheumatoid Arthritis: Table 1

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.698-698

2015

Volltextzugriff (PDF)

THU0059 Reduction of inflammation with abatacept and tocilizumab results in lower N-terminal pro brain natriuretic peptide levels in patients with rheumatoid arthritis: Results from two prospective cohort studies

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.172-173

2013

Volltextzugriff (PDF)

OP0112 Therapeutic drug monitoring to optimise switching between biologic agents in rheumatoid arthritis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.106

2018

Volltextzugriff (PDF)

AB0837 The effect of anti-tnf on renal function in patients with ankylosing spondylitis: a prospective cohort study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1546

2018

Volltextzugriff (PDF)

AB0265 Non-Canonical NF-κB Signaling in Microvessels of Atherosclerotic Lesions in Coronary Arteries Is Associated with Inflammatory Cell Infiltration and Myocardial Infarction

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.990-990

2016

Volltextzugriff (PDF)

FRI0148 Determination of The Lipid Profile in Active Disease Leads To Incorrect Cardiovascular Risk Prediction in Early RA Patients

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.482

2016

Volltextzugriff (PDF)

AB0226 Decline in anti-ccp and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1297

2018

Volltextzugriff (PDF)

THU0205 The effect of certolizumab drug concentration and anti-drug antibodies on tnf neutralisation

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.322

2018

Volltextzugriff (PDF)

THU0211 Six months after treatment discontinuation tnf is still in complex with adalimumab

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.325

2018

Volltextzugriff (PDF)

AB0236 Development and validation of a sensitive lc-ms/ms-based method for analysis of enzymatic activity of folylpolyglutamate synthetase and methotrexate polyglutamates in peripheral blood mononuclear cells of rheumatoid arthritis patients

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1300

2018

Volltextzugriff (PDF)

AB1279 Efficacious transition from reference product infliximab to the biosimilar in daily practice

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1733

2018

Volltextzugriff (PDF)

SAT0337 Biologic dmards and psoriatic arthritis in europe in 2016/2017: characteristics of patients starting tnf-inhibitors or ustekinumab in the ongoing psabio observational cohort study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1033

2018

Volltextzugriff (PDF)

THU0141 Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobra-light trial

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.290

2018

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(70)
Buchkapitel
(2)

Sprache

Englisch
(65)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Rheumatoid Arthritis
(13)
Humans
(8)
Patients
(8)
Monoclonal Antibodies
(7)
Science & Technology
(7)
Life Sciences & Biomedicine
(6)
Psoriatic Arthritis
(6)
Rheumatology
(6)
Ankylosing Spondylitis
(5)
Cardiovascular Diseases
(5)
Immunotherapy
(5)
Remission
(5)
Arthritis
(4)
Tumors
(4)
Arthritis, Rheumatoid - Epidemiology
(3)
Biological And Medical Sciences
(3)
Cohort Studies
(3)
Drugs
(3)
Enzyme-Linked Immunosorbent Assay
(3)
Etanercept
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial

Tumor necrosis factor blocking therapy and congestive heart failure in patients with inflammatory rheumatic disorders: a systematic review

SP0013 Is It Enough Just To Treat Inflammation To Reduce Cardiovascular Risk?

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women

In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study

Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence

SP0117 Rheumatic diseases and cardiovascular risk: Implications for clinical practice

FRI0148 Determination of The Lipid Profile in Active Disease Leads To Incorrect Cardiovascular Risk Prediction in Early RA Patients: Table 1

Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease – the eye for a heart study

THU0116 Lipid profile and cardiovascular risk in subjects at risk for developing rheumatoid arthritis

Association of Somatic Comorbidities and Comorbid Depression With Mortality in Patients With Rheumatoid Arthritis: A 14‐Year Prospective Cohort Study

SAT0131 Uric Acid is Associated with Metabolic Syndrome in Longstanding Rheumatoid Arthritis: Table 1

THU0059 Reduction of inflammation with abatacept and tocilizumab results in lower N-terminal pro brain natriuretic peptide levels in patients with rheumatoid arthritis: Results from two prospective cohort studies

OP0112 Therapeutic drug monitoring to optimise switching between biologic agents in rheumatoid arthritis

AB0837 The effect of anti-tnf on renal function in patients with ankylosing spondylitis: a prospective cohort study

AB0265 Non-Canonical NF-κB Signaling in Microvessels of Atherosclerotic Lesions in Coronary Arteries Is Associated with Inflammatory Cell Infiltration and Myocardial Infarction

FRI0148 Determination of The Lipid Profile in Active Disease Leads To Incorrect Cardiovascular Risk Prediction in Early RA Patients

AB0226 Decline in anti-ccp and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial

THU0205 The effect of certolizumab drug concentration and anti-drug antibodies on tnf neutralisation

THU0211 Six months after treatment discontinuation tnf is still in complex with adalimumab

AB0236 Development and validation of a sensitive lc-ms/ms-based method for analysis of enzymatic activity of folylpolyglutamate synthetase and methotrexate polyglutamates in peripheral blood mononuclear cells of rheumatoid arthritis patients

AB1279 Efficacious transition from reference product infliximab to the biosimilar in daily practice

SAT0337 Biologic dmards and psoriatic arthritis in europe in 2016/2017: characteristics of patients starting tnf-inhibitors or ustekinumab in the ongoing psabio observational cohort study

THU0141 Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobra-light trial

Suchergebnisse filtern